NF2L2_HUMAN - dbPTM
NF2L2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID NF2L2_HUMAN
UniProt AC Q16236
Protein Name Nuclear factor erythroid 2-related factor 2
Gene Name NFE2L2
Organism Homo sapiens (Human).
Sequence Length 605
Subcellular Localization Cytoplasm, cytosol. Nucleus. Cytosolic under unstressed conditions, translocates into the nucleus upon induction by electrophilic agents.
Protein Description Transcription activator that binds to antioxidant response (ARE) elements in the promoter regions of target genes. Important for the coordinated up-regulation of genes in response to oxidative stress. May be involved in the transcriptional activation of genes of the beta-globin cluster by mediating enhancer activity of hypersensitive site 2 of the beta-globin locus control region..
Protein Sequence MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
28 (in isoform 2)Ubiquitination-3.4021906983
28UbiquitinationDILWRQDIDLGVSRE
HHHHHCCCCCCCCHH
3.4027667366
37UbiquitinationLGVSREVFDFSQRRK
CCCCHHHHCHHHHHH
7.2224816145
40PhosphorylationSREVFDFSQRRKEYE
CHHHHCHHHHHHHHH
25.3122558124
44UbiquitinationFDFSQRRKEYELEKQ
HCHHHHHHHHHHHHH
67.8321906983
44 (in isoform 1)Ubiquitination-67.8321906983
48 (in isoform 2)Ubiquitination-11.0321906983
48UbiquitinationQRRKEYELEKQKKLE
HHHHHHHHHHHHHHH
11.0327667366
53UbiquitinationYELEKQKKLEKERQE
HHHHHHHHHHHHHHH
60.4224816145
64UbiquitinationERQEQLQKEQEKAFF
HHHHHHHHHHHHHHH
70.7027667366
64 (in isoform 1)Ubiquitination-70.7021906983
210PhosphorylationENDKLVETTMVPSPE
CCCEEEEEEEECCCC
16.8330266825
211PhosphorylationNDKLVETTMVPSPEA
CCEEEEEEEECCCCC
11.5830266825
215PhosphorylationVETTMVPSPEAKLTE
EEEEEECCCCCCCEE
24.7830266825
229PhosphorylationEVDNYHFYSSIPSME
EEECCEECCCCCHHH
6.5427642862
243PhosphorylationEKEVGNCSPHFLNAF
HCHHHCCCHHHHHHH
25.9626074081
301PhosphorylationSISNSMPSPATLSHS
CCCCCCCCCHHHHHH
20.65-
344PhosphorylationAEFNDSDSGISLNTS
CCCCCCCCCCCCCCC
41.8122751928
347PhosphorylationNDSDSGISLNTSPSV
CCCCCCCCCCCCCCC
21.0622751928
351PhosphorylationSGISLNTSPSVASPE
CCCCCCCCCCCCCCC
17.6922751928
356PhosphorylationNTSPSVASPEHSVES
CCCCCCCCCCCCCCC
28.7622751928
374PhosphorylationGDTLLGLSDSEVEEL
CCEEECCCHHHHHHH
36.97-
395PhosphorylationVKQNGPKTPVHSSGD
CCCCCCCCCCCCCCC
33.4129449344
399PhosphorylationGPKTPVHSSGDMVQP
CCCCCCCCCCCCCCC
35.9329449344
400PhosphorylationPKTPVHSSGDMVQPL
CCCCCCCCCCCCCCC
24.7629449344
408PhosphorylationGDMVQPLSPSQGQST
CCCCCCCCCCCCCCC
29.2325159151
410PhosphorylationMVQPLSPSQGQSTHV
CCCCCCCCCCCCCCC
43.5029449344
414PhosphorylationLSPSQGQSTHVHDAQ
CCCCCCCCCCCCCCC
27.5729449344
415PhosphorylationSPSQGQSTHVHDAQC
CCCCCCCCCCCCCCC
21.7429449344
425PhosphorylationHDAQCENTPEKELPV
CCCCCCCCCCCCCCC
15.5529449344
432UbiquitinationTPEKELPVSPGHRKT
CCCCCCCCCCCCCCC
19.7329967540
433PhosphorylationPEKELPVSPGHRKTP
CCCCCCCCCCCCCCC
24.1930266825
437MethylationLPVSPGHRKTPFTKD
CCCCCCCCCCCCCCC
50.92112847407
438AcetylationPVSPGHRKTPFTKDK
CCCCCCCCCCCCCCC
55.6719273602
439UbiquitinationVSPGHRKTPFTKDKH
CCCCCCCCCCCCCCC
24.4829967540
439PhosphorylationVSPGHRKTPFTKDKH
CCCCCCCCCCCCCCC
24.48-
443AcetylationHRKTPFTKDKHSSRL
CCCCCCCCCCCCHHH
66.2219273602
445AcetylationKTPFTKDKHSSRLEA
CCCCCCCCCCHHHHH
47.1219273602
446UbiquitinationTPFTKDKHSSRLEAH
CCCCCCCCCHHHHHH
40.9329967540
447PhosphorylationPFTKDKHSSRLEAHL
CCCCCCCCHHHHHHH
23.93-
462N-linked_GlycosylationTRDELRAKALHIPFP
CHHHHHHHHHCCCCC
45.0831398338
462AcetylationTRDELRAKALHIPFP
CHHHHHHHHHCCCCC
45.0819273602
462UbiquitinationTRDELRAKALHIPFP
CHHHHHHHHHCCCCC
45.0829967540
472AcetylationHIPFPVEKIINLPVV
CCCCCHHHHHCCCCC
49.4719273602
472N-linked_GlycosylationHIPFPVEKIINLPVV
CCCCCHHHHHCCCCC
49.4731398338
487AcetylationDFNEMMSKEQFNEAQ
CHHHHCCHHHCCHHH
37.3214212485
487N-linked_GlycosylationDFNEMMSKEQFNEAQ
CHHHHCCHHHCCHHH
37.3231398338
499N-linked_GlycosylationEAQLALIRDIRRRGK
HHHHHHHHHHHHHCC
33.8731398338
506AcetylationRDIRRRGKNKVAAQN
HHHHHHCCCHHHHHH
52.3519273602
508AcetylationIRRRGKNKVAAQNCR
HHHHCCCHHHHHHHH
36.4219273602
516AcetylationVAAQNCRKRKLENIV
HHHHHHHHHHHHHHH
56.9614212473
516UbiquitinationVAAQNCRKRKLENIV
HHHHHHHHHHHHHHH
56.96-
518SumoylationAQNCRKRKLENIVEL
HHHHHHHHHHHHHHH
64.29-
518SumoylationAQNCRKRKLENIVEL
HHHHHHHHHHHHHHH
64.29-
518AcetylationAQNCRKRKLENIVEL
HHHHHHHHHHHHHHH
64.2919273602
518UbiquitinationAQNCRKRKLENIVEL
HHHHHHHHHHHHHHH
64.2929967540
524UbiquitinationRKLENIVELEQDLDH
HHHHHHHHHHHHHHH
42.6729967540
525UbiquitinationKLENIVELEQDLDHL
HHHHHHHHHHHHHHH
5.0529967540
531UbiquitinationELEQDLDHLKDEKEK
HHHHHHHHHHHHHHH
41.9229967540
532UbiquitinationLEQDLDHLKDEKEKL
HHHHHHHHHHHHHHH
8.1529967540
533AcetylationEQDLDHLKDEKEKLL
HHHHHHHHHHHHHHH
61.4914212483
536AcetylationLDHLKDEKEKLLKEK
HHHHHHHHHHHHHHH
70.9914212459
538AcetylationHLKDEKEKLLKEKGE
HHHHHHHHHHHHHCC
70.9114212479
538UbiquitinationHLKDEKEKLLKEKGE
HHHHHHHHHHHHHCC
70.9129967540
541AcetylationDEKEKLLKEKGENDK
HHHHHHHHHHCCCHH
68.7514212463
543AcetylationKEKLLKEKGENDKSL
HHHHHHHHCCCHHHH
70.6819273602
544UbiquitinationEKLLKEKGENDKSLH
HHHHHHHCCCHHHHH
39.7829967540
548UbiquitinationKEKGENDKSLHLLKK
HHHCCCHHHHHHHHH
67.5129967540
548AcetylationKEKGENDKSLHLLKK
HHHCCCHHHHHHHHH
67.5119273602
549PhosphorylationEKGENDKSLHLLKKQ
HHCCCHHHHHHHHHH
24.7224719451
551UbiquitinationGENDKSLHLLKKQLS
CCCHHHHHHHHHHHH
35.8929967540
554AcetylationDKSLHLLKKQLSTLY
HHHHHHHHHHHHHHH
44.8519273602
554UbiquitinationDKSLHLLKKQLSTLY
HHHHHHHHHHHHHHH
44.8529967540
555AcetylationKSLHLLKKQLSTLYL
HHHHHHHHHHHHHHH
57.3419273602
558UbiquitinationHLLKKQLSTLYLEVF
HHHHHHHHHHHHHHH
17.5529967540
558PhosphorylationHLLKKQLSTLYLEVF
HHHHHHHHHHHHHHH
17.5519668370
559PhosphorylationLLKKQLSTLYLEVFS
HHHHHHHHHHHHHHH
28.1919668370
561PhosphorylationKKQLSTLYLEVFSML
HHHHHHHHHHHHHHH
10.8229759185
569N-linked_GlycosylationLEVFSMLRDEDGKPY
HHHHHHHCCCCCCCC
36.3131398338
574UbiquitinationMLRDEDGKPYSPSEY
HHCCCCCCCCCCHHC
53.7729967540
574N-linked_GlycosylationMLRDEDGKPYSPSEY
HHCCCCCCCCCCHHC
53.7731398338
576PhosphorylationRDEDGKPYSPSEYSL
CCCCCCCCCCHHCCE
36.3821690096
577PhosphorylationDEDGKPYSPSEYSLQ
CCCCCCCCCHHCCEE
30.4019668370
596AcetylationGNVFLVPKSKKPDVK
CCEEEEECCCCCCCC
68.3821196497
599AcetylationFLVPKSKKPDVKKN-
EEEECCCCCCCCCC-
54.2421196497

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
40SPhosphorylationKinasePKC_GROUP-PhosphoELM
40SPhosphorylationKinasePKC-Uniprot
40SPhosphorylationKinasePKC-FAMILY-GPS
40SPhosphorylationKinasePKCZQ05513
PSP
40SPhosphorylationKinasePKCIP41743
PSP
344SPhosphorylationKinaseGSK3BP49841
PSP
347SPhosphorylationKinaseGSK3BP49841
PSP
374SPhosphorylationKinaseAMPKA1Q13131
PSP
395TPhosphorylationKinaseCDK5Q00535
PSP
408SPhosphorylationKinaseAMPKA1Q13131
PSP
433SPhosphorylationKinaseCDK5Q00535
PSP
433SPhosphorylationKinaseAMPKA1Q13131
PSP
439TPhosphorylationKinaseCDK5Q00535
PSP
576YPhosphorylationKinaseFYNP06241
PSP
576YPhosphorylationKinaseFGRP09769
PSP
576YPhosphorylationKinaseSRCP12931
PSP
576YPhosphorylationKinaseYESP07947
PSP
-KUbiquitinationE3 ubiquitin ligaseBTRCQ9Y297
PMID:24658274
-KUbiquitinationE3 ubiquitin ligaseKEAP1Q14145
PMID:14585973
-KUbiquitinationE3 ubiquitin ligaseRBX1P62877
PMID:23274085

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
40SOxidation

-
40SPhosphorylation

-
596KAcetylation

21196497
599KAcetylation

21196497

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of NF2L2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CBP_HUMANCREBBPphysical
11683914
KEAP1_MOUSEKeap1physical
9887101
KEAP1_MOUSEKeap1genetic
9887101
KEAP1_HUMANKEAP1physical
17462537
TIF1A_HUMANTRIM24physical
20211142
KEAP1_HUMANKEAP1physical
15601839
CUL3_HUMANCUL3physical
15367669
NCOR2_HUMANNCOR2physical
15870285
CBP_HUMANCREBBPphysical
18241676
TYY1_HUMANYY1physical
20309604
MYC_HUMANMYCphysical
20232342
BACH1_HUMANBACH1physical
15734732
KPCD_HUMANPRKCDphysical
19920073
KEAP1_HUMANKEAP1physical
19920073
CBP_HUMANCREBBPphysical
19273602
G45IP_HUMANGADD45GIP1physical
20427290
KEAP1_HUMANKEAP1physical
20463144
PGAM5_HUMANPGAM5physical
18387606
KEAP1_HUMANKEAP1physical
18387606
KEAP1_HUMANKEAP1physical
20484052
KEAP1_HUMANKEAP1physical
16888629
KEAP1_HUMANKEAP1physical
12145307
ENC1_HUMANENC1physical
17875699
ENC1_HUMANENC1physical
18981988
KEAP1_HUMANKEAP1physical
18981988
MAFG_HUMANMAFGphysical
22942279
MYC_HUMANMYCphysical
22942279
PPARG_MOUSEPpargphysical
10930400
SUMO1_HUMANSUMO1physical
23543742
SUMO2_HUMANSUMO2physical
23543742
SIAH2_HUMANSIAH2physical
23645672
NFE2_HUMANNFE2physical
23661758
MAFG_HUMANMAFGphysical
23661758
ATF4_HUMANATF4physical
23661758
ENC1_HUMANENC1physical
20511222
AHR_HUMANAHRphysical
20395535
RBMX_HUMANRBMXphysical
21988832
KEAP1_HUMANKEAP1physical
23986495
BRCA1_HUMANBRCA1physical
23857982
KEAP1_HUMANKEAP1physical
23857982
AKT1_HUMANAKT1physical
24704364
MK08_HUMANMAPK8physical
24704364
MK09_HUMANMAPK9physical
24704364
MP2K1_HUMANMAP2K1physical
24704364
MP2K2_HUMANMAP2K2physical
24704364
KEAP1_HUMANKEAP1physical
24704364
KEAP1_HUMANKEAP1physical
22448038
MK07_HUMANMAPK7physical
23043106
HDAC1_HUMANHDAC1physical
22308472
HDAC2_HUMANHDAC2physical
22308472
HDAC3_HUMANHDAC3physical
22308472
TNNT1_HUMANTNNT1physical
25416956
WAC_HUMANWACphysical
25416956
TCF20_HUMANTCF20physical
24416372
UBC_HUMANUBCphysical
25742418
TIF1B_HUMANTRIM28physical
25995248
KEAP1_HUMANKEAP1physical
25628777
KEAP1_HUMANKEAP1physical
26536456
JUN_HUMANJUNphysical
20194533
CADH1_HUMANCDH1physical
22302998
KEAP1_HUMANKEAP1physical
22302998
KEAP1_HUMANKEAP1physical
27212020
PAQR3_HUMANPAQR3physical
27212020
KEAP1_HUMANKEAP1physical
22331464
KEAP1_HUMANKEAP1physical
28638054
KEAP1_HUMANKEAP1physical
28533375
KEAP1_HUMANKEAP1physical
28939422

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of NF2L2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Acetylation-deacetylation of the transcription factor Nrf2 (nuclearfactor erythroid 2-related factor 2) regulates its transcriptionalactivity and nucleocytoplasmic localization.";
Kawai Y., Garduno L., Theodore M., Yang J., Arinze I.J.;
J. Biol. Chem. 286:7629-7640(2011).
Cited for: ACETYLATION AT LYS-596 AND LYS-599, DEACETYLATION BY SIRT1, ANDSUBCELLULAR LOCATION.

TOP